Contact:Novavax, Inc.Barclay A. PhillipsSVP, Chief Financial Officer and TreasurerAndrea N. Flynn, Ph.D.Associate Director, Investor Relationsir@novavax.com240-268-2000Russo Partners, LLCDavid SchullTodd Davenport, Ph.D.firstname.lastname@example.org@russopartnersllc.com212-845-4271
GAITHERSBURG, Md., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced Stanley C Erck, President and Chief Executive Officer, will present at the 28 th Annual Piper Jaffray Healthcare Conference. Conference details are as follows: Date: Tuesday, November 29, 2016Time: 3:30 pm U.S. Eastern TimeLocation: New York Palace Hotel, New York, New YorkLive webcast: novavax.com, "Investors"/ "Events" A replay of the presentation will also be accessible under the "Investors/Events" section of the Novavax website at novavax.com. About Novavax Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.